Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6SPW

Structure of protein kinase CK2 catalytic subunit with the CK2beta-competitive bisubstrate inhibitor ARC3140

Summary for 6SPW
Entry DOI10.2210/pdb6spw/pdb
Related5NUY
DescriptorCasein kinase II subunit alpha, ARC3140, SODIUM ION, ... (5 entities in total)
Functional Keywordsprotein kinase ck2 casein kinase 2 bisubstrate inhibitor, transferase
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight50036.47
Authors
Niefind, K.,Schnitzler, A. (deposition date: 2019-09-03, release date: 2020-01-29, Last modification date: 2024-10-23)
Primary citationPietsch, M.,Viht, K.,Schnitzler, A.,Ekambaram, R.,Steinkruger, M.,Enkvist, E.,Nienberg, C.,Nickelsen, A.,Lauwers, M.,Jose, J.,Uri, A.,Niefind, K.
Unexpected CK2 beta-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
Bioorg.Chem., 96:103608-103608, 2020
Cited by
PubMed Abstract: Protein kinase CK2, a heterotetrameric holoenzyme composed of two catalytic chains (CK2α) attached to a homodimer of regulatory subunits (CK2β), is a target for drug development for cancer therapy. Here, we describe the tetraiodobenzimidazole derivative ARC-3140, a bisubstrate inhibitor addressing the ATP site and the substrate-binding site of CK2 with extraordinary affinity (K = 84 pM). In a crystal structure of ARC-3140 in complex with CK2α, three copies of the inhibitor are visible, one of them at the CK2β interface of CK2α. Subsequent interaction studies based on microscale thermophoresis and fluorescence anisotropy changes revealed a significant impact of ARC-3140 and of its tetrabromo equivalent ARC-1502 on the CK2α/CK2β interaction. A structural inspection revealed that ARC-3140, unlike CK2β antagonists described so far, interferes with both sub-interfaces of the bipartite CK2α/CK2β interaction. Thus, ARC-3140 is a lead for the further development of highly effective compounds perturbating the quaternary structure of the CK2αβ holoenzyme.
PubMed: 32058103
DOI: 10.1016/j.bioorg.2020.103608
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.599 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon